GFR PHARMACEUTICALS ANNOUNCES THE SIGNING OF A LETTER OF INTENT WITH HARBIN YINHAI TECHNOLOGY

GFR Pharmaceuticals Inc. (GFRP) (OTCBB:GFRP) President and CEO, Richard Pierce announced the signing of a Letter of Intent and Plan of Exchange with Harbin Yinhai Technology Development Ltd. (YHT). Harbin Yinhai Technology Development Co., Ltd., established in 1998, is a professional commercial instrument printing enterprise. The business scope of the company covers the printing of bank deposit books, deposit receipts, computer bills and other financial notes, and printing of standard forms for banks and insurance companies, single purpose invoices and other certificates, etc.

CCNMatthews (http://www.ccnmatthews.com/news/releasesfr/show.jsp?action=showRelease&actionFor=553770)